Vertebroplasty And Kyphoplasty Needles Market Size, Share & Trends Analysis Report By Procedure (Kyphoplasty Procedures), By End Use (Hospitals, Ambulatory Surgical Centers), By Region, And Segment Forecasts, 2025 - 2030

Market Size & Trends

The global vertebroplasty and kyphoplasty needles market size was valued at USD 915.5 million in 2024 and is anticipated to grow at a CAGR of 4.9% over the forecast period. The rising prevalence of spinal injuries from vehicle accidents and sports incidents is driving demand for vertebroplasty and kyphoplasty needles. In addition, the aging population, increasingly affected by osteoporosis, contributes to market expansion. These factors underscore the growing need for minimally invasive procedures to address spinal fractures.

An increase in spinal injuries caused by vehicle accidents and sports incidents is boosting the demand for vertebroplasty and kyphoplasty needles. These procedures provide minimally invasive solutions for spinal fractures. This trend is contributing to the market's growth. According to the World Health Organization (WHO), globally, over 15 million people live with spinal cord injuries (SCI), primarily caused by preventable traumas such as falls, road accidents, or violence. SCI increases the risk of severe secondary conditions, leading to higher mortality rates and reduced economic and educational opportunities. Comprehensive prevention, treatment, rehabilitation, and healthcare are vital to addressing SCI's individual and societal impact.

The aging population faces a rising prevalence of osteoporosis, a condition that weakens bones and increases fracture risks. This drives demand for treatments and medical devices to manage bone fractures, including vertebroplasty and kyphoplasty needles. According to the Johns Hopkins Arthritis Center, in the U.S., 30% of Caucasian postmenopausal women have osteoporosis, while 54% have osteopenia, with low bone mass becoming more prevalent with age. Osteoporosis affects 14% of women aged 50-59, rising to 70% in those aged 80 or older.

Procedure Insights

The kyphoplasty procedures segment accounted for the largest share of 60.4% in 2024 and is expected to grow at the fastest CAGR of 5.0% over the forecast period. This growth can be attributed to the growing integration of advanced minimally invasive technologies to improve procedural outcomes and streamline workflows in spinal fracture treatments. For instance, in June 2024, Medtronic and Merit Medical Systems collaborated to co-market Merit's Bone Biopsy Systems with Medtronic's Kyphon Balloon Kyphoplasty (BKP) in the US. This partnership combines Merit's biopsy expertise with Medtronic's minimally invasive vertebral compression fracture (VCF) treatment to enhance procedural outcomes and simplify hospital workflows.

The vertebroplasty procedures segment is expected to grow significantly over the forecast period. The increasing incidence of vertebral compression fractures (VCF), particularly in the aging population, has driven the demand for vertebroplasty procedures as osteoporosis and bone diseases become more prevalent. Technological advancements in needle design and injection techniques have enhanced the safety and effectiveness of these procedures, contributing to their growing adoption.

End Use Insights

The hospitals segment dominated the market with a share of 59.7% in 2024. The increasing prevalence of spinal disorders, particularly osteoporosis, is driving demand for vertebroplasty and kyphoplasty in hospitals. Enhanced healthcare infrastructure and advanced medical technologies enable hospitals to perform these procedures more effectively. Rising awareness of minimally invasive surgeries is encouraging both patients and healthcare providers to choose these options for their lower risk and faster recovery benefits.

The ambulatory surgical centers (ASC) segment is projected to grow at the fastest CAGR of 5.0% over the forecast period. This growth can be attributed to the increasing demand for minimally invasive procedures that improve clinical outcomes, enhance workflow efficiency, and reduce healthcare costs. For instance, in April 2022, GE Healthcare and Medtronic announced a collaboration to address the increasing demand for outpatient care in Ambulatory Surgery Centers (ASCs) and Office-Based Labs (OBLs). The partnership combines GE’s imaging, monitoring, and ultrasound technologies with Medtronic’s extensive product portfolio to enhance efficiency, workflow, and clinical outcomes.

Regional Insights

North America vertebroplasty and kyphoplasty needles market held the largest share of 39.4% in 2024. The increasing prevalence of osteoporosis and related fractures, particularly among the aging population in North America, is driving the demand for vertebroplasty and kyphoplasty needles. According to Osteoporosis Canada, osteoporosis affects both women and men, with 1 in 3 women and 1 in 5 men experiencing an osteoporotic fracture in their lifetime. Bone health is crucial from childhood, as peak bone mass is reached by age 30. In Canada, over 2.3 million people are living with osteoporosis, and it is responsible for more than 80% of fractures in people over 50. Hip fracture patients face a high risk of re-fracturing, and a significant portion of those with hip fractures will die within a year.

U.S. Vertebroplasty And Kyphoplasty Needles Market Trends

The U.S. vertebroplasty and kyphoplasty needles market held a dominant position in 2024 due to the rising incidence of spinal cord injuries, particularly among young males. For instance, approximately 18,000 new spinal cord injuries (SCI) occur annually in the U.S., based on an incidence rate of 54 per million people, with a population of around 330 million. As of 2022, an estimated 302,000 people lived with SCI, ranging between 255,000 and 383,000. Men account for 79% of SCI cases, often due to violence or sports-related injuries. The average age of injury is 43, with nearly half of all injuries occurring between ages 16 and 30, and 19 being the most common age for injury.

Europe Vertebroplasty And Kyphoplasty Needles Market Trends

The Europe vertebroplasty and kyphoplasty needles market was identified as a lucrative region in 2024. The aging population in Europe, with a higher prevalence of osteoporosis and spinal fractures, increases the demand for vertebroplasty and kyphoplasty procedures. In addition, the preference for minimally invasive surgeries, which offer faster recovery and fewer complications, drives the market for specialized needles. These factors contribute to the growing need for vertebroplasty and kyphoplasty treatments across Europe.

Asia Pacific Vertebroplasty And Kyphoplasty Needles Market Trends

The Asia Pacific vertebroplasty and kyphoplasty needles market is anticipated to grow at a CAGR of 6.0% during the forecast period. The increasing prevalence of spine-related surgeries, particularly among the aging population in the Asia Pacific region, driven by age-related spinal conditions and comorbidities, is fueling the demand for vertebroplasty and kyphoplasty needles. According to the Australian Spine Registry Annual Report 2023, the registry included 4,554 surgery participants, 52% males and 48% females, and a median age of 62 for males and 65 for females. The largest group undergoing spine surgery was in the 70-79 age range, followed by those aged 60-69. There was a discrepancy between surgeon-reported comorbidities and the American Society of Anesthesiologists (ASA) classification, with 63.1% of patients reporting no comorbidities by surgeons, compared to 22.5% in the ASA classification. Patients undergoing discectomy, ACDF, and isthmic spondylolisthesis surgery were generally younger and had fewer comorbidities than the overall cohort.

The China vertebroplasty and kyphoplasty needles market held the largest market share in 2024. China's aging population drives demand for advanced medical devices such as vertebroplasty and kyphoplasty needles. According to the National Bureau of Statistics of China, China is the only country with over 200 million elderly people. By the end of 2022, 280.04 million were aged 60 and above, making up 19.8% of the population. The elderly population is projected to grow, reaching 524 million by 2052.

Japan vertebroplasty and kyphoplasty needles market is expected to grow at the fastest CAGR over the forecast period. Japan's advanced medical technology and innovative spinal treatment tools improve the effectiveness and safety of vertebroplasty and kyphoplasty procedures. In addition, the country's strong healthcare infrastructure and favorable reimbursement policies make these treatments more accessible, driving market growth.

Key Vertebroplasty And Kyphoplasty Needles Company Insights

Some of the key companies in the vertebroplasty and kyphoplasty needles market include Stryker, Medtronic, IZI Medical Products, Globus Medical, BPB medica—Biopsybell, and others. Organizations are focusing on increasing their customer base to gain a competitive edge in the industry. Therefore, key players are taking several strategic initiatives, such as mergers and acquisitions and partnerships with other major companies. 

• Medtronic is a global medical technology company that designs, develops, and manufactures various medical devices for treating heart valve disorders, heart failure, vascular diseases, neurological disorders, and musculoskeletal issues. The company also provides biologic solutions for orthopedics and dental markets.
• Merit Medical Systems develops single-use medical devices for interventional and diagnostic procedures, including vertebroplasty and kyphoplasty needles, embolotherapy products, and fluid dispensing systems. Their products are widely used in cardiology, radiology, oncology, vascular surgery, and pain management.

Recent Developments

• In October 2024, Globus Medical expanded its orthopedic trauma product line with several innovations, including the TENSOR Suture Button System, ANTHEM II Distal Radius Volar Plates, and AUTOBAHN Trochanteric Nail PRO Instruments. These products received FDA clearance and are designed to enhance surgical precision and improve patient outcomes.

• In August 2024, Stryker agreed to acquire Vertos Medical, a company specializing in minimally invasive treatments for chronic lower back pain caused by lumbar spinal stenosis. Vertos' "mild" procedure offers a solution for pain relief and improved mobility, reducing the need for major surgery.

• In August 2021, IZI Medical Products launched Vertefix HV Cement with Insite tracking beads, designed to improve real-time flow visualization during vertebroplasty and kyphoplasty procedures. This new cement features high viscosity, long working time, and enhanced safety through better tracking.

Vertebroplasty And Kyphoplasty Needles Market Report Scope

Global Vertebroplasty And Kyphoplasty Needles Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the global vertebroplasty and kyphoplasty needles market report based on procedure, end use, and region.

• Procedure Outlook (Revenue, USD Million, 2018 - 2030)

  • Kyphoplasty Procedures

  • Vertebroplasty Procedures

    • Directional Vertebroplasty Needles

    • Straight Vertebroplasty Needles

• End Use Outlook (Revenue, USD Million, 2018 - 2030)

  • Hospitals

  • Ambulatory Surgical Centers

• Regional Outlook (Revenue, USD Million, 2018 - 2030

  • North America

    • U.S.

    • Canada

    • Mexico

  • Europe

    • UK

    • Germany

    • France

    • Italy

    • Spain

    • Norway

    • Sweden

    • Denmark

  • Asia Pacific

    • Japan

    • China

    • India

    • Australia

    • South Korea

    • Thailand

  • Latin America

    • Brazil

    • Argentina

  • Middle East and Africa (MEA)

    • South Africa

    • Saudi Arabia

    • UAE

    • Kuwait